ProQR Therapeutics NV (PRQR)
1.67
-0.03
(-1.76%)
USD |
NASDAQ |
Jun 18, 16:00
1.67
0.00 (0.00%)
After-Hours: 16:02
ProQR Therapeutics Cash from Financing (Quarterly): -0.4551M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.4551M |
| December 31, 2023 | -1.175M |
| September 30, 2023 | -0.3045M |
| June 30, 2023 | -0.7054M |
| March 31, 2023 | -0.2782M |
| December 31, 2022 | 12.41M |
| September 30, 2022 | -44.02M |
| June 30, 2022 | -0.3493M |
| March 31, 2022 | -0.6093M |
| December 31, 2021 | 32.33M |
| September 30, 2021 | 25.53M |
| June 30, 2021 | 100.44M |
| March 31, 2021 | 3.597M |
| December 31, 2020 | -0.1665M |
| September 30, 2020 | 15.57M |
| June 30, 2020 | 0.5406M |
| March 31, 2020 | 0.6147M |
| December 31, 2019 | 56.20M |
| September 30, 2019 | -0.3235M |
| June 30, 2019 | -0.2239M |
| March 31, 2019 | 0.5418M |
| Date | Value |
|---|---|
| December 31, 2018 | 2.689M |
| September 30, 2018 | 98.88M |
| June 30, 2018 | 0.1544M |
| March 31, 2018 | 0.3698M |
| December 31, 2017 | 19.46M |
| September 30, 2017 | 7.056M |
| June 30, 2017 | 1.366M |
| March 31, 2017 | 2.292M |
| December 31, 2016 | 0.1942M |
| September 30, 2016 | -0.0025M |
| June 30, 2016 | -0.0007M |
| March 31, 2016 | 0.2041M |
| December 31, 2015 | 0.4185M |
| September 30, 2015 | 0.0089M |
| June 30, 2015 | 1.378M |
| March 31, 2015 | -0.0079M |
| December 31, 2014 | 0.7404M |
| September 30, 2014 | 104.52M |
| June 30, 2014 | 54.18M |
| March 31, 2014 | -0.0205M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-44.02M
Minimum
Sep 2022
100.44M
Maximum
Jun 2021
9.931M
Average
-0.1952M
Median
Cash from Financing (Quarterly) Benchmarks
| uniQure NV | 0.00 |
| Merus NV | 30.16M |
| argenx SE | -- |
| Pharming Group | -2.471M |
| Pharvaris NV | 0.8636M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.44M |
| Cash from Investing (Quarterly) | -19.26M |
| Free Cash Flow | -43.28M |
| Free Cash Flow Per Share (Quarterly) | -0.2112 |
| Free Cash Flow to Equity (Quarterly) | -17.20M |
| Free Cash Flow to Firm (Quarterly) | -17.23M |
| Free Cash Flow Yield | -31.92% |